SCHEMBL6982568

SCHEMBL6982568

Nc1nc(N)nc(-c2ccc(S(=O)(=O)c3ccccc3)cc2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.62
ADORA2A P29274 2/20 0.62
ADORA2B P29275 2/20 0.62
ADORA1 P30542 2/20 0.62
POLB P06746 1/20 0.62
HTR6 P50406 3/20 0.50
CA2 P00918 3/20 0.49
CA9 Q16790 3/20 0.49
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
CA7 P43166 1/20 0.49
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
IKBKB O14920 1/20 0.45
BRAF P15056 1/20 0.45
HSP90AA1 P07900 1/20 0.45
HSP90AB1 P08238 1/20 0.45
PIK3CA P42336 1/20 0.44
PIK3C3 Q8NEB9 1/20 0.44
MAPT P10636 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8130030 0.81 ADORA3 (0.41) ADORA3ADORA2AADORA2BADORA1POLB
SCHEMBL6984930 0.81 TSHR (0.52) ADORA3ADORA2AADORA1PIK3CAMAPT
Benzoguanamine SCHEMBL8930589 0.79 ADORA2A (0.76) ADORA3ADORA2AADORA2BADORA1POLB
SCHEMBL6983430 0.79 KEAP1 (0.61) ADORA3ADORA2AADORA2BADORA1POLB
SCHEMBL6977514 0.78 ADORA1 (0.91) ADORA3ADORA2AADORA2BADORA1POLB
Benzoguanamine SCHEMBL27898 0.78 ADORA2A (1.00) ADORA3ADORA2AADORA2BADORA1POLB
Benzoguanamine SCHEMBL28634836 0.78 ADORA2A (1.00) ADORA3ADORA2AADORA2BADORA1POLB
Benzoguanamine SCHEMBL917182 0.78 ADORA2A (1.00) ADORA3ADORA2AADORA2BADORA1POLB
SCHEMBL27549110 0.77 ADORA3 (0.50) ADORA3ADORA2AADORA2BADORA1POLB
Benzoguanamine SCHEMBL8509865 0.77 ADORA2A (0.86) ADORA3ADORA2AADORA2BADORA1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
CN-1290264-A Triazine angiogenesis inhibitors ABBOTT LAB (US) 2001-04-04 CN disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed